ADCT

ADC Therapeutics Stock Price

24.77
-0.18 (-0.72%)
Upgrade to Real-Time
Afterhours (Closed)
24.77

Low
20.01

52 Week Range

High
56.5899

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.18 -0.72% 24.77 20:00:00
Open Price Low Price High Price Close Price Prev Close
24.96 23.95 25.01 24.77 24.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,172 268,356 $ 24.45 $ 6,562,301 323,544 20.01 - 56.5899
Last Trade Time Type Quantity Stock Price Currency
19:00:00 2,721 $ 24.77 USD

ADC Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.94B 78.27M 31.11M $ - $ - -3.57 -6.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

ADC Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADCT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.1925.7622.6523.96420,5021.586.81%
1 Month20.7125.7620.5022.75347,6874.0619.6%
3 Months23.8128.3420.0123.21343,3720.964.03%
6 Months36.5037.8220.0126.23324,762-11.73-32.14%
1 Year42.5056.589920.0130.64264,819-17.73-41.72%
3 Years30.0056.589920.0131.07271,054-5.23-17.43%
5 Years30.0056.589920.0131.07271,054-5.23-17.43%

ADC Therapeutics Description

ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ADCT-402, ADCT-301, ADCT-602, and ADCT-601.


Your Recent History
NYSE
ADCT
ADC Therap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.